European Archives - Page 139 of 1585 - European Medical Journal

Metabolomic Markers of Neurotransmitter-Related Metabolism in Women with Ovarian Endometriomas

Endometriosis, including ovarian endometriomas, is associated with chronic inflammation, pelvic pain, fatigue, and affective symptoms…

TBS in Women with POI and Correlation with Bone Mineral Density

Oestrogen deficiency associated with premature ovarian insufficiency (POI) results in increased osteoclastic activity leading to decreased…

City of Cambridge

£450m invested in UK by AZ and Boehringer

In good news for UK life sciences investment, two companies have made pledges to build new facilities.

Gut Microbiota Linked to Coronary Heart Disease Risk

The findings revealed a significantly higher abundance of an Eubacterium species, with 100% sequence similarity to Eubacterium liposum, in patients with CHD compared with both control and hyperlipidaemia groups.

knee osteoarthritis

Incentive Programme Boosts Activity in Knee Osteoarthritis

Behavioural incentives increase daily steps in knee osteoarthritis, but neither incentives nor corticosteroid injections improve symptoms in clinical trial findings.

Holistic Care in the Diabetes Review: The Alphabet Strategy

Tune in to the latest EMJ Webinar, exploring holistic diabetes care through the practical and evidence-based Alphabet Strategy. Guest…

Potential Benefits of Sunlight for Heart, Infection, and Cancer Risk

The systemic effects of sunlight may include lower mortality and reduced disease burden, according to a decade-long review.

Health + AI Tech Show: NHS England Rolls Out AI Discharge Summary Tool

An AI tool for patient discharge summaries has been rolled out at an NHS hospital trust, presented in an exclusive demo at the Health + AI Tech Show on 29th April 2026.

How HCPs consumed medical content in 2025

Discover an infographic on how HCPs consumed medical content in 2025. EMJ data reveals format preferences and more.

hepatocellular carcinoma

Perioperative Immunotherapy Improves Liver Cancer Outcomes

Perioperative immunotherapy improves outcomes in hepatocellular carcinoma, showing reduced recurrence risk and better event free survival in high-risk patients.